Search Trends

Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies

Staff April 7, 2025

VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...

Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test

Staff April 1, 2025

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

Staff March 31, 2025

Integration of Arabic opens opportunities in the Middle East and supports Company’s strategic global expansion goals Drug Screening Reader -...

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

Staff March 28, 2025

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology...

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

Staff March 27, 2025

INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts...

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Staff March 26, 2025

Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive...

Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch

Staff March 25, 2025

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Staff March 20, 2025

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights

Staff March 3, 2025

DALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce...

Safety Strips Invites Media Offices to Receive Free Fentanyl Test Kits to Enhance Public Safety

Staff February 14, 2025

Providing Journalists and Event Organizers with Essential Tools for Overdose PreventionToronto, Ontario--(Newsfile Corp. - February 14, 2025) - Safe Supply...

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

Staff February 10, 2025

Company highlights key milestones achieved in 2024, growing revenues and progress towards U.S. expansion in 2025NEW YORK, Feb. 10, 2025...

Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

Staff February 7, 2025

Avon Freight Group selects INBS’ fingerprint drug testing for three UK sites, reinforcing workplace safety and efficiency INBS surpasses 400+...

Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales

Staff February 6, 2025

Gross profit expected to surge by 32.6% Unaudited revenue of $0.61 million for fiscal Q2 and $1.48 million for the...

Human Organs-on-Chips Market to Reach USD 1019 Million by 2031 | 31.2% CAGR Growth Forecast – Valuates Reports

Staff January 31, 2025

BANGALORE, India, Jan. 31, 2025 /PRNewswire/ -- Human Organs-on-Chips Market is Segmented by Type (Brain-on-a-chip, Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip,...

Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Staff January 31, 2025

Multilingual upgrade will make INBS’ Drug Screening System accessible to over 4 billion users worldwide, including users across the Americas,...

Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Staff January 29, 2025

Quantum Traffic Management transitions from saliva and urine testing to non-invasive, in-house fingerprint sweat-based drug screening Most recent client added...

Okomera to Present Automated Desktop Organoid Screening Instrument for Oncology Drug Discovery at SLAS 2025 in San Diego

Staff January 28, 2025

PARIS, Jan. 28, 2025 /PRNewswire/ -- Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will...

Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions

Staff January 28, 2025

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...

Analytical Standards Market size to increase by USD 657.8 Million between 2023 to 2028, Market Segmentation by Type, Application, Geography, Methodology , Technavio

Staff January 17, 2025

NEW YORK, Jan. 17, 2025 /PRNewswire/ -- The global analytical standards market size is estimated to grow by USD 657.8 million...

Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology

Staff January 9, 2025

Cannabix Technologies Inc. Cannabix Breath Collection Unit (“BCU”) with Breath Cartridge technology VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE)...